JTT-861, Placebo tablet for JTT-861
AT861-G-22-002
Phase 2 small_molecule active
Quick answer
JTT-861, Placebo tablet for JTT-861 for Heart Failure (Heart Failure with Reduced Ejection Fraction) is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Heart Failure (Heart Failure with Reduced Ejection Fraction)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active